PULSAR MAX, PULSAR, DISCOVERY, MERIDIAN , PULSAR MAX II, DISCOVERY II, VIRTUS PLUS II, INTELIS II and CONTAK TR pacemakers 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Guidant Corporation 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2005-07-19
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Press release
  • 원인
    Corrective action of guidant implantable cardiac pacemakers 19 july 2005 the department of health has been notified by the guidant corporation of an “urgent medical device safety information and corrective action” concerning some of their implanted cardiac pacemakers. the pacemakers in question may experience premature battery depletion without warning, inappropriate pacing and early display of replacement indicators. the affected pacemakers are pulsar max, pulsar, discovery, meridian , pulsar max ii, discovery ii, virtus plus ii, intelis ii and contak tr pacemakers manufactured between 25 november, 1997 and 26 october, 2000. if these devices exhibit the above failure mode, patients may notice prolonged rapid heart beating and develop dizziness. in serious circumstances, though uncommon, they may develop heart failure symptoms such as shortness of breath and loss of consciousness. the manufacturer has sent letters to doctors with patients implanted with the pacemakers to alert them of the incident, and advise replacement of the pacemakers where necessary. affected patients are urged to contact their doctors for advice. guidant hong kong limited has set up two hot lines 2593 2210 and 6292 2308 for public enquiry during office hours. the department of health has alerted the hospital authority, private hospitals and medical associations of the corrective action undertaken by guidant on some of their cardiac pacemakers.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Press release: Corrective Action of Guidant implantable cardiac pacemakers
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    DH